Women Home > Gildagia
You should talk with your healthcare provider prior to using Gildagia if you have:
- A clotting disorder or have ever had a blood clot
- Had a heart attack or stroke
- High blood pressure (hypertension)
- Chest pain
- Had yellowing of the whites of the eyes or skin (jaundice) during a prior pregnancy or oral contraceptive use
- Liver disease, such as liver failure, cirrhosis, hepatitis, or liver tumors
- High cholesterol
- Gallbladder disease
- Diabetes
- Depression
- Migraines or other severe headaches
- Cancer (or if you have had cancer in the past)
- Unexplained vaginal bleeding.
Also, let your healthcare provider know if you:
- Smoke cigarettes
- Have an upcoming surgery
- Are pregnant or thinking of becoming pregnant (see Ovcon and Pregnancy, as Gildagia is a generic version of Ovcon)
- Are breastfeeding (see Ovcon and Breastfeeding).
Make sure to tell your healthcare provider about all other medicines you are taking, including prescription and nonprescription medications, vitamins, and herbal supplements.
(Click Precautions and Warnings With Gildagia to learn more, including information on who should not take this contraceptive.)
Gildagia is a combined oral contraceptive, which means it contains two different types of hormones. It contains both an estrogen (ethinyl estradiol) and a progestin (norethindrone). Combined oral contraceptives are the most common type of birth control pills used today. In general, combined oral contraceptives are more effective than progestin-only birth control pills.
The hormones in Gildagia primarily prevent pregnancy by stopping ovulation (the maturation and release of eggs from the ovaries). However, Gildagia also works to prevent pregnancy in two other, minor ways. Gildagia changes the cervical mucus (the fluid of the cervix, which is the lower, narrow part of the uterus that is connected to the vagina), making it more difficult for sperm to enter the uterus. Lastly, Gildagia alters the lining of the uterus (called the endometrium), making it less receptive to an embryo.